Skip to main content
    F

    Fresenius Medical Care Corporation (FMS)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $22.03
    +0.43 (+1.99%)

    Market Cap: $11.43B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Fresenius Medical Care Corporation (FMS) P/E Ratio & Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Fresenius Medical Care (FMS) trades at 8.9x trailing earnings and 0.5x sales. Its P/S of 0.5x is below its 5-year median of 0.7x. Its forward P/E is 9.6x. The median P/E across 12 similar companies is 24.2x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 7.3% lower over the next year. Its free cash flow yield is 17.7%.

    MultipleValue
    P/E (trailing)8.9x
    Forward P/E9.6x
    Price to sales0.5x
    Price to book0.8x
    EV/EBITDA5.5x
    Price to FCF5.6x
    EV/FCF9.2x
    PEG1.0
    FCF yield17.7%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 58.3% below 1.2x and its P/B is 50.0% below 1.6x.

    MultipleCurrent5-year median10-year median
    P/S0.5x0.7x1.2x
    P/B0.8x1.0x1.6x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/S ranged from 0.6x in 2023 to 1.6x in 2017.

    Year endPriceP/SP/B
    2025$23.820.6x0.8x
    2024$22.640.6x0.9x
    2023$20.830.6x1.2x
    2022$16.340.7x1.0x
    2021$32.461.4x2.0x
    2020$41.561.6x1.6x
    2019$36.831.2x2.4x
    2018$32.391.0x1.3x
    2017$52.551.6x2.7x
    2016$42.211.4x2.5x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    P/E history is shown only for companies that report in US dollars.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About FMS

    What is FMS's forward P/E ratio?

    Fresenius Medical Care has a forward P/E ratio of 9.6x.

    Is FMS stock overvalued?

    GNG's valuation label for FMS is Undervalued. Its P/E of 8.9x compares with a median of 24.2x across 12 similar companies.

    What is FMS's price to sales ratio?

    Fresenius Medical Care has a price to sales ratio of 0.5x.

    What is FMS's PEG ratio?

    Fresenius Medical Care has a PEG ratio of 1.0.